Key Takeaways in Colorectal Cancer Screening

In the final episode, ‘Key Takeaways in Colorectal Cancer Screening,’ the faculty emphasize that while colonoscopy remains the gold standard, noninvasive stool-based tests are appropriate alternatives for average-risk patients who decline invasive screening. They stress that symptomatic or high-risk individuals—including those with family history, genetic syndromes, inflammatory bowel disease, or prior polyps—require diagnostic colonoscopy rather than screening tests. The discussion highlights emerging DNA- and RNA-based technologies as promising tools to expand screening uptake, particularly given workforce limitations in gastroenterology. With the screening age lowered to 45, capacity constraints have prompted ongoing conversations about how best to allocate colonoscopy resources. Ultimately, the segment reinforces the importance of individualized risk assessment, patient education, and shared decision-making to reduce colorectal cancer morbidity and mortality. Thank you for watching this HCP Live Peers &